Furthermore, TMB and MSI were connected with RACGAP1 expression in various human malignancies; hence, these results could designate RACGAP1 as a reliable prognostic biomarker, a marker for patients’ responsiveness to immunotherapy, and a promising target for cancer therapeutics. The gene discussed is RACGAP1; the disease is cancer.